U.S. flag

An official website of the United States government

NM_002769.5(PRSS1):c.*8A>G AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 12, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000588285.1

Allele description [Variation Report for NM_002769.5(PRSS1):c.*8A>G]

NM_002769.5(PRSS1):c.*8A>G

Genes:
TRB:T cell receptor beta locus [Gene - HGNC]
PRSS1:serine protease 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q34
Genomic location:
Preferred name:
NM_002769.5(PRSS1):c.*8A>G
HGVS:
  • NC_000007.14:g.142753028A>G
  • NG_001333.2:g.586696A>G
  • NG_008307.3:g.8545A>G
  • NM_002769.5:c.*8A>GMANE SELECT
  • LRG_1013t1:c.*8A>G
  • LRG_1013:g.8545A>G
  • NC_000007.13:g.142460879A>G
  • NM_002769.4:c.*8A>G
Links:
dbSNP: rs750733084
NCBI 1000 Genomes Browser:
rs750733084
Molecular consequence:
  • NM_002769.5:c.*8A>G - 3 prime UTR variant - [Sequence Ontology: SO:0001624]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000698043Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Sep 12, 2016)
germlineclinical testing

LabCorp Variant Classification Summary - May 2015.docx

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000698043.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The PRSS1 c.*8A>G variant is located in the 3' UTR causing the alteration of a non-conserved nucleotide. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 3/121358 (1/40453), predominantly in the African cohort, 3/10400 (1/3466), which does exceed the estimated maximal expected allele frequency for a pathogenic PRSS1 variant of 1/200000. Therefore, suggesting the variant is a polymorphism found in population(s) of African origin. However, the database indicates that this observance does not meet the filter threshold (low coverage), along with the cohort containing individuals that could harbor a PRSS1 phenotype, therefore these three observations in the ExAC cohort need to be cautiously considered. In addition, the variant of interest, to our knowledge, has not been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor has it been functionally assessed. Therefore, due to the limited available information, the variant of interest has been classified as a "Variant of Uncertain Significance (VUS)," until additional information becomes available.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 29, 2022